Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC 23: The ILUMIEN IV Trial
Author(s): Ziad A Ali Added: 1 year ago
ESC 2023 — Dr Ziad Ali (DeMatteis St Francis, US) joins us to discuss the findings from the ILUMIEN IV clinical trial (NCT03507777). ILUMIEN IV (Abbott Medical Devices)is a prospective, single-blind clinical trial aiming to compare optical coherence tomography (OCT) to an angiography-guided stent implantation strategy. The trial investigated which method achieved a larger post-percutaneous… View more

Prevention & Chronic Conditions

MI/ACS
HFA 23: IRONMAN: Anemia, Iron Deficiency and Quality of Life
Author(s): Paul Kalra Added: 1 year ago
ESC-HFA 23 – Prof Paul Kalra (Portsmouth Hospitals NHS Trust, UK) joins us onsite to discuss the IRONMAN trial (NCT02642562). The IRONMAN trial aimed to study the effectiveness of intravenous iron in patients with heart failure and iron deficiency when compared to standard care. It showed that administration of IV FDI led to lower rates of recurrent heart failure hospitalisations and… View more

Heart Failure
ESC 23: The HEART-FID Study
Author(s): Robert Mentz Added: 1 year ago
ESC 2023 — Dr Robert Mentz (Duke University Medical Center, US) joins us to provide a succinct summary of the findings and key take-home messages from the HEART-FID study (NCT03037931). HEART-FID(American Regent, Inc.) aimed to determine the safety and efficacy of iron therapy using intravenous (IV) ferric carboxymaltose (FCM) as compared to a placebo in the treatment of patients with heart… View more

Heart Failure
HFA 23: IRONMAN: Reasons for Hospitalisation and Biomarkers
Author(s): John GF Cleland Added: 1 year ago
ESC-HFA 23 - Prof John Cleland (University of Glasgow, UK) joins us onsite to discuss the IRONMAN trial (NCT02642562). IRONMAN was a randomised, open-label multicenter trial, which aimed to assess the effectiveness of intravenous iron in patients with heart failure and iron deficiency as compared to standard care. It demonstrated that the administration of IV FDI was associated with lower rates… View more

Heart Failure
ACC 25: The Phase 3 REVERSE-IT Trial
Author(s): Deepak L Bhatt Added: 1 month ago
ACC 2025 - Phase three results of the use of bentracimab in patients who need urgent ticagrelor reversal show significantly restored platelet function as measured by percent inhibition of P2Y12 Reaction Unit (PRU).Dr Deepak L Bhatt (Mount Sinai Fuster Heart Hospital, New York, US) joins us onsite at ACC 2025 to discuss phase three results from the multi-center, open-label, single-arm REVERSE-IT… View more

Anticoagulation
Dr Armin Luik is an electrophysiologist at Medical clinic IV, Karlsruhe, Germany. Dr Luik specialises in pacemaker/defibrillator implantations, coronary interventions and mitral valve clipping. View more
ESC 23: Day 3 Wrap-Up with Dr Alasnag and Dr Al-Shaibi
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 1 year ago
ESC 23 — We are joined by Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (The King Fahd Armed Forces Hospital, SA) for an insightful wrap-up of the third day of ESC Congress 2023. New data releases covered in detail include: ILUMIEN IV OCTIVUS OCTOBER OCT Vs IVUS Vs Angiography Guidance Meta-analysis MULTISTARS-AMI ATTRibute Recorded on-site at ESC Congress 2023, Amsterdam. Editors: Mirjam Boros… View more

Intervention
Aortic Endograft Infection: Timely Recognition Is Key
Author(s): Salwan Al-Hani , Luai Madanat , Aiden Van Loo , et al Added: 4 months ago

Vascular Disease and Surgery

Imaging & Diagnostics
HFA 23: APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis
Author(s): Marianna Fontana Added: 1 year ago
ESC-HFA 23 — We are joined by Prof Marianna Fontana (University College London, UK), as she outlines the key findings from the phase 3 APOLLO-B study (Alnylam Pharmaceuticals) (NCT03997383). APOLLO-B investigated the use of patisiran, a transthyretin-directed small interfering RNA, in a cohort of patients with cardiac amyloidosis. 360 patients were enrolled in the trial and were randomized 1:1… View more

Heart Failure